Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Proshares Trust (ZBIO) EBITDA Margin (2023 - 2025)

Historic EBITDA Margin for Zenas BioPharma (ZBIO) over the last 3 years, with Q1 2025 value amounting to 336.26%.

  • Zenas BioPharma's EBITDA Margin changed N/A to 336.26% in Q1 2025 from the same period last year, while for Sep 2025 it was 1266.81%, marking a year-over-year change of. This contributed to the annual value of 3136.62% for FY2024, which is 30625300.0% down from last year.
  • As of Q1 2025, Zenas BioPharma's EBITDA Margin stood at 336.26%.
  • In the past 5 years, Zenas BioPharma's EBITDA Margin ranged from a high of 71.23% in Q3 2023 and a low of 1049.26% during Q4 2024
  • Moreover, its 3-year median value for EBITDA Margin was 336.26% (2025), whereas its average is 438.1%.